2010 News

November 17, 2010

Morphotek, Inc. Announces Initiation of A Sponsored Research Agreement with Hokkaido University to Evaluate Amatuximab (MORAb-009) in Advanced Pancreatic Cancer
Read More

October 21, 2010

Morphotek, Inc. Awarded $2.5 Million from U.S. Department of Defense to Continue Development of Therapeutic Antibodies Against Microbial Bioweapons
Read More

September 28, 2010

Morphotek, Inc. Announces Selection of A Therapeutic Monoclonal Antibody for Clinical Development Under Terms of Collaboration with Human Genome Sciences
Read More

May 18, 2010

Joye L. Bramble, PH.D. Appointed Vice President, Pilot Plant Operations for Morphotek, Inc.
Read More

April 19, 2010

Champions Biotechnology, Inc. and Morphotek®, Inc. Announce Agreement for an Oncology Evaluation Using Biomerk Tumorgraft™ Platform
Read More

March 8, 2010

Morphotek, Inc. Breaks Ground for 60,000-Square-Foot Manufacturing Plant
Read More